Company news
JMDC Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Summary of Financial Statements for the Three Months Ended June 30, 2026 [IFRS] (Consolidated)
August 5, 2026
Notice of Confirmed Details of Share Subscription Rights (Stock Options Offered)
July 16, 2026
Notice of Issuance of Share Subscription Rights (Stock Options Offered)
June 25, 2026
Summary of Financial Statements for the Fiscal Year Ended March 31, 2026 (Consolidated)
May 8, 2026
FY2025 Financial Briefing Material
May 8, 2026
Summary of Financial Statements for the Six Months Ended September 30, 2025 (Consolidated)
November 6, 2025
FY2025 Q2 Financial Briefing Material
November 6, 2025
Summary of Financial Statements for the Three Months Ended June 30, 2026 (Consolidated)
August 6, 2025
FY2025 Q1 Financial Briefing Material
August 6, 2025
FY2023 Financial Briefing Material
May 7, 2024
Summary of Financial Statements for the Six Months Ended September 30, 2023 (Consolidated)
November 2, 2023
FY2023 Q2 Financial Briefing Material
November 2, 2023
Summary of Financial Statements for the Three Months Ended June 30, 2023 (Consolidated)
August 9, 2023
FY2023 Q1 Financial Briefing Material
August 9, 2023
Notice Concerning Borrowing of Funds
July 27, 2022
(Progress of disclosure matters)Notice of Additional Acquisition of Shares in Real World Data
July 20, 2022
Notice of Acquisition of Shares in Real World Data (to Make It JMDC’s Subsidiary)
July 12, 2022
Notice of Our New Initiative in the Field of Clinical Trials
July 1, 2022
Notice of Partial Amendment of Articles of Incorporation
May 23, 2022
Explanation Material on the Capital and Business Partnership with OMRON Corporation
February 24, 2022
Notice of Partnership with OMRON Corporation, Secondary Offering of Shares, and Changes in Parent Company, etc., and the Major and Largest Shareholder
February 22, 2022
Summary of Financial Statements for the Nine Months Ended December 31, 2021 (Consolidated)
February 7, 2022
FY2021 Q3 Financial Briefing Material
February 7, 2022
Notice Concerning Application for Selecting Prime Market in the New Market Segments
December 20, 2021
First Pharmaceutical Approval in Japan for Chest X-ray AI Algorithm that Supports Diagnosis of Patients with Infectious Pneumonia, Including COVID-19
December 15, 2021
Notice of Listing Market Change to the First Section of the Tokyo Stock Exchange
November 28, 2021
Notice of Approval for Change of Listing Market to the First Section ofthe Tokyo Stock Exchange
November 22, 2021
Decks
- Q1 FY2027/3 Earnings Presentation
Earnings · 21 slides · Aug 5, 2026